The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL)...read more
Alzamend Neuro, a preclinical biotech developing therapies for Alzheimer's disease, raised $12.5 million by offering 2.5 million shares at $5, as expected. The company noted in its prospectus that an affiliate of founder and Executive Chairman Todd Ault may...read more
Alzamend Neuro, a preclinical biotech developing therapies for Alzheimer's disease, announced terms for its IPO on Tuesday. The Tampa, FL-based company plans to raise $12.5 million by offering 2.5 million shares at $5 per share. Insider Digital Power...read more
The IPO market had a tumultuous week with five IPOs and three postponements: Brazilian customer service platform Zenvia (ZENV), mortgage insurance spinoff Enact Holdings (ACT), and hearing care services provider ...read more
US IPO Weekly Recap: IPO market in full swing as biotechs lead a 16 IPO week
The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL)...read more
Alzheimer's biotech Alzamend Neuro prices $12.5 million IPO at $5 per share
Alzamend Neuro, a preclinical biotech developing therapies for Alzheimer's disease, raised $12.5 million by offering 2.5 million shares at $5, as expected. The company noted in its prospectus that an affiliate of founder and Executive Chairman Todd Ault may...read more
Preclinical Alzheimer's biotech Alzamend Neuro sets terms for $13 million IPO
Alzamend Neuro, a preclinical biotech developing therapies for Alzheimer's disease, announced terms for its IPO on Tuesday. The Tampa, FL-based company plans to raise $12.5 million by offering 2.5 million shares at $5 per share. Insider Digital Power...read more
US IPO Weekly Recap: Postponements abound in a turbulent 5 IPO week
The IPO market had a tumultuous week with five IPOs and three postponements: Brazilian customer service platform Zenvia (ZENV), mortgage insurance spinoff Enact Holdings (ACT), and hearing care services provider ...read more